Literature DB >> 21674082

Therapeutic applications of gold complexes: lipophilic gold(III) cations and gold(I) complexes for anti-cancer treatment.

Chi-Ming Che1, Raymond Wai-Yin Sun.   

Abstract

Gold and its complexes have long been known to display unique biological and medicinal properties. Extensive cell-based (in vitro) and animal (in vivo) studies have revealed the potent anti-cancer activities of diverse classes of gold(I) and gold(III) complexes. Most of the reported anti-cancer active gold complexes are highly cytotoxic and unstable under physiological conditions, which hamper their development to be launched clinically. Several clinical reports showed that lipophilic organic cations are promising anti-cancer drug candidates targeting to mitochondria. Through metal-ligand coordination, gold(I) and gold(III) ions can form stable lipophilic cations containing organic ligands having tunable lipophilicity and diverse functionalities. The present highlight summarizes the recent development of lipophilic gold(III) cations and gold(I) complexes with promising anti-cancer activities. This journal is © The Royal Society of Chemistry 2011

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21674082     DOI: 10.1039/c1cc10860c

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  17 in total

1.  Expanding the biological utility of bis-NHC gold(i) complexes through post synthetic carbamate conjugation.

Authors:  Sajal Sen; Yue Li; Vincent Lynch; Kuppuswamy Arumugam; Jonathan L Sessler; Jonathan F Arambula
Journal:  Chem Commun (Camb)       Date:  2019-08-29       Impact factor: 6.222

2.  N-heterocyclic carbene gold(I) and silver(I) complexes bearing functional groups for bio-conjugation.

Authors:  Mary E Garner; Weijia Niu; Xigao Chen; Ion Ghiviriga; Khalil A Abboud; Weihong Tan; Adam S Veige
Journal:  Dalton Trans       Date:  2015-01-28       Impact factor: 4.390

3.  Synthesis and anti-cancer activities of a water soluble gold(III) porphyrin.

Authors:  Aaron D Lammer; Melissa E Cook; Jonathan L Sessler
Journal:  J Porphyr Phthalocyanines       Date:  2015-01       Impact factor: 1.811

4.  Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties.

Authors:  Malgorzata Frik; Jacob Fernández-Gallardo; Oscar Gonzalo; Víctor Mangas-Sanjuan; Marta González-Alvarez; Alfonso Serrano del Valle; Chunhua Hu; Isabel González-Alvarez; Marival Bermejo; Isabel Marzo; María Contel
Journal:  J Med Chem       Date:  2015-07-22       Impact factor: 7.446

5.  Gold(I) complexes of 9-deazahypoxanthine as selective antitumor and anti-inflammatory agents.

Authors:  Ján Vančo; Jana Gáliková; Jan Hošek; Zdeněk Dvořák; Lenka Paráková; Zdeněk Trávníček
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240

6.  Targeting Antioxidant Pathways with Ferrocenylated N-Heterocyclic Carbene Supported Gold(I) Complexes in A549 Lung Cancer Cells.

Authors:  J F Arambula; R McCall; K J Sidoran; D Magda; N A Mitchell; C W Bielawski; V M Lynch; J L Sessler; K Arumugam
Journal:  Chem Sci       Date:  2015-10-29       Impact factor: 9.825

7.  Metal complexes as potential modulators of inflammatory and autoimmune responses.

Authors:  Chung-Hang Leung; Sheng Lin; Hai-Jing Zhong; Dik-Lung Ma
Journal:  Chem Sci       Date:  2014-11-07       Impact factor: 9.825

8.  Heteroleptic Copper(I) Complexes of "Scorpionate" Bis-pyrazolyl Carboxylate Ligand with Auxiliary Phosphine as Potential Anticancer Agents: An Insight into Cytotoxic Mode.

Authors:  Rais Ahmad Khan; Mohammad Usman; Rajakumar Dhivya; Perumalsamy Balaji; Ali Alsalme; Hamad AlLohedan; Farukh Arjmand; Khalid AlFarhan; Mohammad Abdulkader Akbarsha; Fabio Marchetti; Claudio Pettinari; Sartaj Tabassum
Journal:  Sci Rep       Date:  2017-03-24       Impact factor: 4.379

9.  New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.

Authors:  Muhammad Altaf; Muhammad Monim-Ul-Mehboob; Abdel-Nasser Kawde; Giuseppe Corona; Roberto Larcher; Marcia Ogasawara; Naike Casagrande; Marta Celegato; Cinzia Borghese; Zahid H Siddik; Donatella Aldinucci; Anvarhusein A Isab
Journal:  Oncotarget       Date:  2017-01-03

10.  A multi-functional PEGylated gold(iii) compound: potent anti-cancer properties and self-assembly into nanostructures for drug co-delivery.

Authors:  Clive Yik-Sham Chung; Sin-Ki Fung; Ka-Chung Tong; Pui-Ki Wan; Chun-Nam Lok; Yanyu Huang; Tianfeng Chen; Chi-Ming Che
Journal:  Chem Sci       Date:  2016-11-22       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.